References Abi-Dargham A, Grace A
Brussels Sprouts: A dense source of fiber and sulfur
1 Education for awareness and health care and control of hyperglycemia, dyslipidemia and hypertension are key strategies for slowing the onset and worsening of DR, similar to other MDS-related complications
Forget DBRCT - it has never published any controlled efficacy trial of any variety in human beings
Mouhammad ZA, Rombaut A, Bermdez MYG, Vohra R, Tribble JR, Williams PA, Kolko M (2025) Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma
While the main substance patent for semaglutide is expected to expire in 2026, other patents, especially those covering specific formulations, uses, and delivery devices, may extend protections into the 2030s, effectively delaying generic entry